| scholarly article | Q13442814 |
| P50 | author | Paul Greengard | Q309979 |
| Per Svenningsson | Q21175215 | ||
| Carol Tamminga | Q29904486 | ||
| Marc Flajolet | Q62673815 | ||
| P2093 | author name string | Brian Alexander | |
| Jennifer Warner-Schmidt | |||
| Margarita Arango-Lievano | |||
| Mary Vernov | |||
| Michael G Kaplitt | |||
| Mihaela Stavarache | |||
| Sergei Musatov | |||
| Subroto Ghose | |||
| Therese Eriksson | |||
| P2860 | cites work | The molecular neurobiology of depression | Q24656261 |
| Genome-wide atlas of gene expression in the adult mouse brain | Q26253934 | ||
| Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation | Q28235087 | ||
| Alterations in 5-HT1B receptor function by p11 in depression-like states | Q28290425 | ||
| The mesolimbic dopamine reward circuit in depression | Q28304016 | ||
| Deep brain stimulation for treatment-resistant depression | Q29616769 | ||
| The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders | Q30888331 | ||
| An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. | Q33828004 | ||
| The cellular neurobiology of depression | Q34236134 | ||
| In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice | Q34292427 | ||
| Serotonin1B receptors: from protein to physiological function and behavior | Q34365298 | ||
| Selective and rapid uptake of adeno-associated virus type 2 in brain | Q34471578 | ||
| Human postmortem tissue: what quality markers matter? | Q34574442 | ||
| Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial | Q34640765 | ||
| Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. | Q34778098 | ||
| A tractography analysis of two deep brain stimulation white matter targets for depression | Q35580398 | ||
| The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice | Q36125191 | ||
| Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects | Q36491567 | ||
| p11 (S100A10)--an inducible adaptor protein that modulates neuronal functions | Q36644963 | ||
| Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism | Q36883134 | ||
| Efferent projections of the infralimbic cortex of the rat | Q41139924 | ||
| Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sens | Q41528963 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals | Q42499994 | ||
| Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. | Q43546120 | ||
| Lack of ventral striatal response to positive stimuli in depressed versus normal subjects | Q48407950 | ||
| Coupling of canine serotonin 5-HT(1B) and 5-HT(1D) receptor subtypes to the formation of inositol phosphates by dual interactions with endogenous G(i/o) and recombinant G(alpha15) proteins. | Q54041152 | ||
| P2507 | corrigendum / erratum | A Correction to the Research Article Titled: "Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens" by Brian Alexander, Jennifer Warner-Schmidt, Therese Eriksson, Carol Tamminga, Margarita Arango-Llievano, Subroto Ghos | Q56501874 |
| A Correction to the Research Article Titled: "Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens" by Brian Alexander, Jennifer Warner-Schmidt, Therese Eriksson, Carol Tamminga, Margarita Arango-Lievano, Subroto Ghose | Q56501992 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 54 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene therapy | Q213901 |
| nucleus accumbens | Q1476178 | ||
| P304 | page(s) | 54ra76 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Science Translational Medicine | Q1573955 |
| P1476 | title | Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens | |
| P478 | volume | 2 |
| Q42701001 | A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors |
| Q37526391 | A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques |
| Q34088430 | A role for p11 in the antidepressant action of brain-derived neurotrophic factor |
| Q36207488 | Ac45 silencing mediated by AAV-sh-Ac45-RNAi prevents both bone loss and inflammation caused by periodontitis |
| Q91559739 | Ahnak scaffolds p11/Anxa2 complex and L-type voltage-gated calcium channel and modulates depressive behavior |
| Q37002871 | Alteration by p11 of mGluR5 localization regulates depression-like behaviors |
| Q37696024 | Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease |
| Q37406212 | Annexin A2 system in human biology: cell surface and beyond |
| Q24627318 | Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans |
| Q28584341 | Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression |
| Q44341273 | Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens |
| Q37192952 | Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11. |
| Q37574670 | Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain |
| Q34090607 | Cell-type specific expression of p11 controls cocaine reward |
| Q36094336 | Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior |
| Q28085697 | Circuit to construct mapping: a mathematical tool for assisting the diagnosis and treatment in major depressive disorder |
| Q41683110 | Depression and addiction comorbidity: towards a common molecular target? |
| Q36737217 | Epigenetic Modulation of Mood Disorders |
| Q34254501 | Epigenetic signaling in psychiatric disorders. |
| Q27318901 | GABAB receptor cell-surface export is controlled by an endoplasmic reticulum gatekeeper |
| Q33818667 | Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome |
| Q36563189 | Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice |
| Q84925593 | Gene therapy for psychiatric disorders |
| Q85789509 | Gene therapy for psychiatric disorders |
| Q92150122 | Hippocampal mossy cell involvement in behavioral and neurogenic responses to chronic antidepressant treatment |
| Q36534907 | Inhibiting periapical lesions through AAV-RNAi silencing of cathepsin K. |
| Q37714447 | Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction |
| Q37334088 | Mechanisms of antidepressant resistance |
| Q26860173 | Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy |
| Q31153904 | Monitoring candidate gene expression variations before, during and after a first major depressive episode in a 51-year-old man. |
| Q39282211 | Neuroanatomic Differences Associated With Stress Susceptibility and Resilience |
| Q30976676 | Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity |
| Q42460272 | Neurons in the ventral striatum exhibit cell-type-specific representations of outcome during learning |
| Q39700861 | Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice. |
| Q34643734 | Next-generation treatments for mental disorders |
| Q36498264 | Opposing roles for serotonin in cholinergic neurons of the ventral and dorsal striatum. |
| Q100416112 | P11 deficiency increases stress reactivity along with HPA axis and autonomic hyperresponsiveness |
| Q36332597 | Pathogenesis of depression: Insights from human and rodent studies |
| Q38151373 | Pivotal role of tissue plasminogen activator in the mechanism of action of electroconvulsive therapy |
| Q64106594 | Potential Protein Target to Therapeutically Restore Positive Mood States in Depression |
| Q36517077 | Probable involvement of p11 with interferon alpha induced depression |
| Q36804730 | RNA interference-mediated silencing of Atp6i prevents both periapical bone erosion and inflammation in the mouse model of endodontic disease |
| Q34663536 | RNAi-mediated silencing of Atp6i and Atp6i haploinsufficiency prevents both bone loss and inflammation in a mouse model of periodontal disease |
| Q94521083 | Reduction of depression-like behavior in rat model induced by ShRNA targeting norepinephrine transporter in locus coeruleus |
| Q26853509 | Review of pharmacological treatment in mood disorders and future directions for drug development. |
| Q36678407 | Serotonin 1B receptor imaging in pathological gambling |
| Q37635780 | Serotonin receptors in depression: from A to B. |
| Q37290664 | Serum S100B represents a new biomarker for mood disorders |
| Q36040298 | Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer |
| Q92377807 | Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects |
| Q97644188 | The Nucleus Accumbens: A Common Target in the Comorbidity of Depression and Addiction |
| Q36395285 | The annexin A2/S100A10 system in health and disease: emerging paradigms |
| Q45368362 | The metastasis-promoting S100A4 protein confers neuroprotection in brain injury |
| Q92987643 | The molecular and cellular mechanisms of depression: a focus on reward circuitry |
| Q36031101 | The role of serotonin receptor subtypes in treating depression: a review of animal studies |
| Q34624535 | p11 and gene therapy for severe psychiatric disorders: a practical goal? |
| Q37601789 | p11 and its role in depression and therapeutic responses to antidepressants |
| Q58699601 | p11 in Cholinergic Interneurons of the Nucleus Accumbens Is Essential for Dopamine Responses to Rewarding Stimuli |
| Q36563103 | p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism |
Search more.